• 1
    Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50: 48192.
  • 2
    Hinuma Y, Nagata K, Hanaoka M et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 647680.
  • 3
    Shimoyama M, Members of the Lymphoma Study Group (198487). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br J Haematol 1991; 79: 42837.
  • 4
    Moriyama K, Muranishi H, Nishimura J, Tanaka K, Asayama R, Takita A. Immunodeficiency in preclinical smoldering adult T-cell leukemia. Jpn J Clin Oncol 1988; 4: 3639.
  • 5
    Katsuki T, Katsuki K, Imai J, Hinuma Y. Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-1): impairment of T-cell control of Epstein–Barr virus-infected B-cells. Jpn J Cancer Res 1987; 78: 63942.
  • 6
    Tachibana N, Okayama A, Ishizaki J. Suppression of tuberculin skin reaction in healthy HTLV-1 carriers from Japan. Int J Cancer 1988; 42: 82931.
  • 7
    Yamada Y. Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. Blood 1983; 61: 1929.
  • 8
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a signal mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 115164.
  • 9
    Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101: 4558.
  • 10
    Shevach EM. CD4+CD25+ suppressor T cells: more questions than answers. Nature Rev 2002; 2: 389400.
  • 11
    Piccirillo CA, Thornton AM. Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol 2004; 25: 37480.
  • 12
    Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 288: 105761.
  • 13
    Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 3306.
  • 14
    Khattri R, Cox T, Yasayko S, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunol 2003; 4: 33742.
  • 15
    Walker MR, Kasprowicz DJ, Gersuk VH et al. Induction of Foxp3 and acquisition of T regulatory activity by stimulated human CD4+CD25T cells. J Clin Invest 2003; 112: 143743.
  • 16
    McHugh RS, Whitters MJ, Piccirillo CA et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2003; 16: 31123.
  • 17
    Bruder D, Probst-Kepper M, Westendorf AM et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004; 34: 62330.
  • 18
    Yamada Y. Features of the cytokines secreted by adult T-cell leukemia (ATL) cells. Leuk Lymphoma 1996; 21: 4437.
  • 19
    Nagata K, Ohtani K, Nakamura M, Sugamura K. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type 1-encoded p40tax protein in the human T-cell line, Jurkat. J Virol 1989; 63: 32206.
  • 20
    Moshe O, Fujisawa R, Nakayama T et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 2002; 99: 150511.
  • 21
    Matsumoto K, Shibata H, Fujisawa J et al. Human T-cell leukemia virus type I Tax protein transforms rat fibroblasts via two distinct pathways. J Virol 1997; 71: 444551.
  • 22
    Hironaka N, Mochida K, Mori N, Maeda M, Yamamoto N, Yamaoka S. Tax-independent constitutive IκB kinase activation in adult T-cell leukemia cells. Neoplasia 2004; 6: 26674.
  • 23
    Sugita S, Kohno T, Yamamoto K et al. Induction of macrophage-inflammatory protein-3α gene expression by TNF-dependent NF-κB activation. J Immunol 2002; 168: 56218.
  • 24
    Karube K, Ohshima K, Tsuchiya T et al. Expression of Foxp3, a key molecule in CD4+CD25+ regulatory T cells in adult T-cell leukemia/lymphoma cells. Br J Haematol 2004; 126: 814.
  • 25
    Ishida T, Iida S, Akatsuka Y et al. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin Cancer Res 2004; 10: 752939.
  • 26
    Nakae S, Asano M, Horai R, Sakaguchi N, Iwakura Y. IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OV40 on T cells. J Immunol 2001; 167: 907.
  • 27
    Iellem A, Mariani M, Lang RR et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J Exp Med 2001; 194: 84753.
  • 28
    Nocentini G, Giunchi L, Ronchetti S et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA 1997; 94: 621621.
  • 29
    Zhao LJ, Giam CZ. Human T-cell lymphotropic virus type I (HTLV-1) transcriptional activator, Tax, enhances CREB binding to HTLV-1 21-base-pair repeats by protein–protein interaction. Proc Natl Acad Sci USA 1992; 89: 70704.
  • 30
    Ballard DW, Bohnein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. HTLV-1 tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science 1988; 241: 16525.
  • 31
    Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 5027.
  • 32
    Hori S, Carvalho TL, Demengeot J. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 2002; 32: 128291.
  • 33
    Yagi H, Nomura T, Nakamura K et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16: 164356.
  • 34
    Matsubara Y, Hori T, Morita R, Sakaguchi S, Uchiyama T. Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells. Leukemia 2005; 10: 4823.
  • 35
    Ronchetti S, Nocentini G, Riccardi C, Pandolfi PP. Role of GITR in activation response of T lymphocytes. Blood 2002; 100: 3502.
  • 36
    Ronchetti S, Zollo O, Bruscoli S et al. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 2004; 34: 61322.
  • 37
    Kanamaru F, Youngnak P, Hashiguchi M et al. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J Immunol 2004; 172: 730614.
  • 38
    Tone M, Tone Y, Adams E, Yates SF et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc Natl Acad Sci USA 2003; 100: 15 059–64.
  • 39
    Ji HB, Liao G, Faubin WA et al. The natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 2004; 172: 58237.
  • 40
    Kwon B, Yu K, Ni J et al. Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J Biol Chem 1999; 274: 605661.
  • 41
    Yu KY, Kim HS, Song SY, Min SS, Jeong JJ, Youn BS. Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells. Biochem Biophys Res Commun 2003; 310: 4338.
  • 42
    Koyanagi Y, Itoyama Y, Nakamura N et al. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 1993; 196: 2533.
  • 43
    Sutton RE, Littman DR. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J Virol 1996; 70: 73226.